Specialty Pharmacy

Initiating biologics before triple therapy increases costs and provides minimal incremental benefit.

An experimental drug reactivated an enzyme to elicit tumor suppression.

Switching from DMARDs to first-line biologics may not be the optimal treatment for RA.

GatherMS aims to fill the resource knowledge gap in the MS landscape.

Women accounted for most of the hospitalization and in-hospital deaths.

Top news of the day from across the health care landscape.

Health care has historically been physician-patient focused, but pharmacists and patients are changing this trend.

Outcomes-based contracting may soon play a role in the service level agreements between a specialty pharmacy provider and a manufacturer.

RA patients can consume up to 14 alcoholic beverages per week without increasing the risk of liver damage, but rates increase with increasing levels of alcohol consumption.

Patient with MS was previously treated for 3 years with natalizumab, a known trigger of progressive multifocal leukoencephalopathy.

Continuous low-dose cisplatin through an implantable device could be a therapeutic option in for patients with ovarian cancer.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Top news of the day from across the health care landscape.

Metastatic urothelial carcinoma drug among key approvals from May 2017.

Statins also found to play key role in preventing cardiovascular events.

Rheumatoid arthritis drug among key FDA drug approvals from last month.

Top news of the week in oncology and cancer drug development.

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

The Centers for Medicare & Medicaid Services seeks to improve accuracy of data reported from direct and indirect remuneration fees.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

HIV-positive individuals are twice as likely to die of smoking than the disease.

Immune checkpoint inhibitors have revolutioned cancer treatment, but not all patients respond to immunotherapy.

Biosimilar programs seeks to increase accessibility to expensive medications.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.

Kevin Mange, MD, MSCE, head of North America Medical Immunology at Sanofi, provides a comprehensive overview of the considerations in the treatment of rheumatoid arthritis, which carries comorbidities that affect multiple organ systems.